Tuberculosis - HealthQuill

Billionaire Bill Gates has pledged $912 million over three years, starting next year, to the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Bill Gates to spend $912 million to fight AIDS, tuberculosis, malaria

Billionaire Bill Gates has pledged $912 million over three years, starting next year, to the Global Fund to Fight AIDS, Tuberculosis and Malaria.

by HealthQuill
September 23, 2025
0 Comments

Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child and maternal deaths, combat infectious diseases, Alzheimer’s, and close down the Gates Foundation on December 31, 2045.

Drugs Health Medical

Gates Foundation to shut in 2045, pledges $200 billion in next 20 years

HQ Team May 8, 2025: Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child.

by HealthQuill
May 8, 2025
0 Comments

Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from Biogen Inc., for an undisclosed amount.

Drugs Medical Pharma

Organon & Co. buys biosimilar from Biogen for an undisclosed sum

HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from.

by HealthQuill
April 2, 2025
0 Comments

Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests for tuberculosis.

Uncategorized

Danaher’s Cepheid gets first WHO prequalification nod for TB tests

Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests.

by HealthQuill
December 5, 2024
0 Comments

Malaria, HIV, and tuberculosis were among a list of 17 disease-causing pathogens where vaccines need to be developed as a priority to reduce regional disease burden, according to the World Health Organization.

Drugs Health Pharma

Malaria, TB among top diseases where vaccines needed most: WHO

Malaria, HIV, and tuberculosis were among a list of 17 disease-causing pathogens where vaccines need to be developed as a priority to reduce.

by HealthQuill
November 5, 2024
0 Comments

Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the highest on records since WHO began global monitoring in 1995.

Drugs Health Medical

Tuberculosis was the world’s top infectious disease killer last year

Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the.

by HealthQuill
October 30, 2024
0 Comments

the BCG vaccine does not provide consistent and optimal protection against TB there is an urgent need for a more effective vaccine.

Drugs Health Opinion Pharma

Opinion: Time to explore a new vaccine, booster for tuberculosis

By K Leelamoni April 30, 2024: Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent — next to.

by HealthQuill
April 30, 2024
2 Comments

The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.

Drugs Health Pharma

First late-stage trial vaccine doses begin in South Africa for tuberculosis

HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.

by HealthQuill
March 20, 2024
0 Comments

Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a health crisis, the WHO stated.

Drugs Health Pharma

Globally, 7.5 million people got tuberculosis last year: WHO report

Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a.